Jyong Biotech Ltd. (MENS)
↓ Download CSV| Metric (FY) | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Operating Income | -$2.61M | -$2.06M | -$2.80M | — |
| Net Income | -$4.67M | -$3.02M | -$4.40M | — |
| EPS (Diluted) | $-0.06 | $-0.04 | $-0.06 | — |
| Total Assets | $20.78M | $6.37M | — | — |
| Total Liabilities | $45.68M | $42.88M | — | — |
| Shareholders' Equity | -$24.91M | -$36.52M | -$34.07M | -$29.63M |
| Operating Cash Flow | -$3.04M | -$3.62M | -$2.60M | — |
| Shares Outstanding | 73.01M | 71.57M | 71.57M | — |